Women's and Men's Hormonal Health

Polycystic Ovary Syndrome: Treatment & Care

Clinical
|
Reading Time: 3 minutes
|
Written on: April 30, 2024
Young smiling woman in a yoga pose, using yoga as a way to reduce her polycystic ovary syndrome (PCOS) symptoms.
Lee este artículo en español >

Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic condition. Although global prevalence rates vary due to factors such as differing diagnostic criteria and substantial geographic differences in medical care access and health education, this disorder has been estimated to affect 4 to 20% of reproductive-age women worldwide.1 In the United States, prevalence is estimated up to 12%,2 and recent reporting indicates the economic burden of PCOS is approximately $8 billion annually in 2020 USD when combining costs for both immediate and long-term health complications.3 

Despite being a common hormone disorder in women of reproductive age, the variation in PCOS phenotypes and symptomatology often leads to a delayed or underdiagnosis.4,5 Reports also indicate that the clinical phenotype of PCOS shows a wide variation depending on a patient’s race and ethnicity.1,6 In addition, some patients who receive a PCOS diagnosis report a high level of dissatisfaction with their health care.7 And unfortunately, not all patients experiencing PCOS symptoms seek care, potentially unaware that treatments, including lifestyle approaches, may provide some symptom relief.5,8,9

PCOS Health Risks

PCOS has been associated with chronic inflammation,10,11 insulin resistance,12 and an overall increase in health risks. Common comorbidities include subfertility and infertility, hypertension, type 2 diabetes, depression, anxiety, sleep apnea, menstrual irregularities, and more.5,12 A 2020 systematic review of 23 cohort studies found that in addition to an increased risk of hypertension and type 2 diabetes, women with PCOS also showed higher serum concentrations of total cholesterol, lower serum concentrations of high-density lipoprotein-C, and increased risks of non-fatal cerebrovascular disease events compared to women without PCOS.13 Women with PCOS are also more likely to have anxiety or depression.14 Additional studies even suggest an association between PCOS and metabolic syndrome in adolescents, with those adolescents with PCOS showing three times greater odds of having metabolic syndrome compared to controls.15 

Diagnosis & Treatment Approaches

Recognizing certain health patterns such as insulin resistance, chronic inflammation, and metabolic disorders as well as PCOS risk factors16 such as obesity, environmental pollutants,17 and gut dysbiosis18,19 may help with early PCOS diagnosis. Functional medicine offers effective tools to help organize a patient’s complete health story and implement personalized interventions.

Recent clinical trials continue to show that lifestyle modifications, including healthy diets, appropriate nutraceuticals, exercise, and mind-body therapies help patients with PCOS alleviate some symptoms and may help reduce ongoing health risks by improving metabolic profiles.5,8,9,20-24 A recent Cochrane review also concluded that lifestyle interventions may improve androgen levels and reduce weight and BMI in women with PCOS.25 A 2021 systematic review that included 11 clinical trials found that both aerobic and resistance training interventions for women with PCOS demonstrated significant improvements in depression and anxiety symptoms in addition to positive improvements in their health-related quality of life.26 

Other interventions and approaches such as traditional Chinese medicine and acupuncture continue to show promise as adjunctive treatments for PCOS.27 While further large-scale trials are still needed, a 2020 meta-analysis of 10 randomized controlled trials (n=737 patients with PCOS) showed significant decreases in BMI and waist to hip ratio in the acupuncture treatment groups compared to controls, in addition to significant improvements in fasting plasma glucose, insulin sensitivity, and triglyceride measurements.28 

Conclusion

Accurate diagnosis followed by multimodal interventions may not only help the immediate concerns of patients with PCOS but may also help improve their overall health in the long-term. Learn more about the complexities of hormonal balance and creating effective and personalized treatment approaches for your patients at IFM’s Hormone Advanced Practice Module (APM). 

New call-to-action

Related Topics

Autumn vegetables, lentils, beans, raw ingredients for cooking on trendy yellow and green background. Embodying the benefits of probiotics on clinical measures or NAFLD/ NASH.
November 7, 2024 | Clinical

MASLD & MASH: Emerging Therapeutics to Enhance Standard of Care

Closeup of hands canning sauerkraut, a fermented food rich in live microbes that can benefit mortality and aging.
October 29, 2024 | Clinical

Hot Topic November 2024: New Study Suggests Foods Rich in Live Microbes Benefit Mortality & Aging

A little girl eating a watermelon at a picnic outside, showing that nutrition interventions in children may be able to help pediatric behavioral and issues related to food and allergies.
October 7, 2024 | Clinical

Nutrition, Social-Emotional Issues, and Children

See all
REFERENCES
  1. Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261-271. doi:10.4103/jhrs.JHRS_95_18
  2. PCOS (polycystic ovary syndrome) and diabetes. Centers for Disease Control and Prevention. Reviewed December 30, 2022. Accessed April 1, 2024. https://www.cdc.gov/diabetes/basics/pcos.html#:~:text=PCOS%20is%20one%20of%20the,US%20women%20of%20reproductive%20age
  3. Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab. 2022;107(2):575-585. doi:10.1210/clinem/dgab613
  4. Hoyos LR, Putra M, Armstrong AA, et al. Measures of patient dissatisfaction with health care in polycystic ovary syndrome: retrospective analysis. J Med Internet Res. 2020;22(4):E16541. doi:10.2196/16541
  5. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi:10.1210/clinem/dgad463
  6. Sendur SN, Yildiz BO. Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review. Reprod Biomed Online. 2021;42(4):799-818. doi:10.1016/j.rbmo.2020.12.006
  7. Elghobashy M, Lau GM, Davitadze M, et al. Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study. Front Endocrinol (Lausanne). 2023;14:1175548. doi:10.3389/fendo.2023.1175548
  8. Khatlani K, Njike V, Costales VC. Effect of lifestyle intervention on cardiometabolic risk factors in overweight and obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2019;17(10):473-485. doi:10.1089/met.2019.0049
  9. Abdolahian S, Tehrani FR, Amiri M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):71. doi:10.1186/s12902-020-00552-1
  10. Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE-D, Amer S. The role of chronic inflammation in polycystic ovarian syndrome-a systematic review and meta-analysis. Int J Mol Sci. 2021;22(5):2734. doi:10.3390/ijms22052734
  11. Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631-643. doi:10.1007/s00404-020-05951-2
  12. Kim KW. Unravelling polycystic ovary syndrome and its comorbidities. J Obes Metab Syndr. 2021;30(3):209-221. doi:10.7570/jomes21043
  13. Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942-960. doi:10.1093/humupd/dmaa029
  14. Wang Y, Ni Z, Li K. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2021;37(12):1072-1078. doi:10.1080/09513590.2021.1942452
  15. Fu L, Xie N, Qu F, Zhou J, Wang F. The association between polycystic ovary syndrome and metabolic syndrome in adolescents: a systematic review and meta-analysis. Reprod Sci. 2023;30(1):28-40. doi:10.1007/s43032-022-00864-8
  16. Singh S, Pal N, Shubham S, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454. doi:10.3390/jcm12041454
  17. Kawa IA, Masood A, Fatima Q, et al. Endocrine disrupting chemical bisphenol A and its potential effects on female health. Diabetes Metab Syndr. 2021;15(3):803-811. doi:10.1016/j.dsx.2021.03.031
  18. Zou Y, Liao R, Cheng R, Chung H, Zhu H, Huang Y. Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: a systematic review and meta-analysis. Microb Pathog. 2023;184:106370. doi:10.1016/j.micpath.2023.106370
  19. Gu Y, Zhou G, Zhou F, et al. Gut and vaginal microbiomes in PCOS: implications for women's health. Front Endocrinol (Lausanne). 2022;13:808508. doi:10.3389/fendo.2022.808508
  20. Moslehi N, Zeraattalab-Motlagh S, Rahimi Sakak F, Shab-Bidar S, Tehrani FR, Mirmiran P. Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials. Nutr Rev. 2023;81(5):555-577. doi:10.1093/nutrit/nuac075
  21. Di Lorenzo M, Cacciapuoti N, Lonardo MS, et al. Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS): a comprehensive review. Curr Nutr Rep. 2023;12(3):527-544. doi:10.1007/s13668-023-00479-8
  22. Menichini D, Ughetti C, Monari F, Di Vinci PL, Neri I, Facchinetti F. Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature. Gynecol Endocrinol. 2022;38(8):623-631. doi:10.1080/09513590.2022.2089106
  23. Hafizi Moori M, Nosratabadi S, Yazdi N, Kasraei R, Abbasi Senjedary Z, Hatami R. The effect of exercise on inflammatory markers in PCOS women: a systematic review and meta-analysis of randomized trials. Int J Clin Pract. 2023;2023:3924018. doi:10.1155/2023/3924018
  24. Dema H, Videtič Paska A, Kouter K, et al. Effects of mindfulness-based therapy on clinical symptoms and DNA methylation in patients with polycystic ovary syndrome and high metabolic risk. Curr Issues Mol Biol. 2023;45(4):2717-2737. doi:10.3390/cimb45040178
  25. Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;3(3):CD007506. doi:10.1002/14651858.CD007506.pub4
  26. Patten RK, Pascoe MC, Moreno-Asso A, Boyle RA, Stepto NK, Parker AG. Effectiveness of exercise interventions on mental health and health-related quality of life in women with polycystic ovary syndrome: a systematic review. BMC Public Health. 2020;21(1):2310. doi:10.1186/s12889-021-12280-9
  27. Hu J, Shi W, Xu J, et al. Complementary and alternative medicine for the treatment of abnormal endometrial conditions in women with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5536849. doi:10.1155/2021/5536849
  28. Zheng R, Qing P, Han M, et al. The effect of acupuncture on glucose metabolism and lipid profiles in patients with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5555028. doi:10.1155/2021/5555028